290 related articles for article (PubMed ID: 29917250)
21. Current Status and Future Prospects for Esophageal Cancer.
Sheikh M; Roshandel G; McCormack V; Malekzadeh R
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765722
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.
Gao S; Zhao ZY; Zhang ZY; Zhang Y; Wu R
Clin Transl Gastroenterol; 2018 Nov; 9(11):203. PubMed ID: 30420592
[TBL] [Abstract][Full Text] [Related]
23. Single-cell RNA sequencing reveals diverse intratumoral heterogeneities and gene signatures of two types of esophageal cancers.
Wu H; Yu J; Li Y; Hou Q; Zhou R; Zhang N; Jing Z; Jiang M; Li Z; Hua Y; Brunicardi FC; Wu S
Cancer Lett; 2018 Dec; 438():133-143. PubMed ID: 30223068
[TBL] [Abstract][Full Text] [Related]
24. The landscape of m6A regulators in esophageal cancer: molecular characteristics, immuno-oncology features, and clinical relevance.
Li Z; Zheng C; Huang L; Yin X; Wang Z; Liu C; Li B
Ann Transl Med; 2022 Dec; 10(24):1347. PubMed ID: 36660671
[TBL] [Abstract][Full Text] [Related]
25. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Xue J; Jia E; Ren N; Xin H
Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
[TBL] [Abstract][Full Text] [Related]
27. Proteogenomic examination of esophageal squamous cell carcinoma (ESCC): new lines of inquiry.
Dagamajalu S; Vijayakumar M; Shetty R; Rex DAB; Narayana Kotimoole C; Prasad TSK
Expert Rev Proteomics; 2020 Sep; 17(9):649-662. PubMed ID: 33151123
[No Abstract] [Full Text] [Related]
28. Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression.
Hoang AT; Vizio B; Chiusa L; Cimino A; Solerio D; Do NH; Pileci S; Camandona M; Bellone G
Int J Med Sci; 2021; 18(6):1406-1414. PubMed ID: 33628097
[TBL] [Abstract][Full Text] [Related]
29. Trends in Esophageal Cancer Mortality and Stage at Diagnosis by Race and Ethnicity in the United States.
Corona E; Yang L; Esrailian E; Ghassemi KA; Conklin JL; May FP
Cancer Causes Control; 2021 Aug; 32(8):883-894. PubMed ID: 34003396
[TBL] [Abstract][Full Text] [Related]
30. Differential Protein Interactome in Esophageal Squamous Cell Carcinoma Offers Novel Systems Biomarker Candidates with High Diagnostic and Prognostic Performance.
Gulfidan G; Beklen H; Sinha I; Kucukalp F; Caloglu B; Esen I; Turanli B; Ayyildiz D; Arga KY; Sinha R
OMICS; 2021 Aug; 25(8):495-512. PubMed ID: 34297901
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
Sun G; Ye H; Wang X; Li T; Jiang D; Qiu C; Dai L; Shi J; Wang K; Song C; Wang P; Zhang J
Cancer Med; 2020 Feb; 9(3):1173-1182. PubMed ID: 31856412
[TBL] [Abstract][Full Text] [Related]
32. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project.
Lindkvist B; Johansen D; Stocks T; Concin H; Bjørge T; Almquist M; Häggström C; Engeland A; Hallmans G; Nagel G; Jonsson H; Selmer R; Ulmer H; Tretli S; Stattin P; Manjer J
BMC Cancer; 2014 Feb; 14():103. PubMed ID: 24548688
[TBL] [Abstract][Full Text] [Related]
33. Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA.
Booka E; Tsubosa Y; Yokota T; Mayanagi S; Ishii K; Urakami K; Ohshima K; Ohnami S; Nagashima T; Yamaguchi K
Esophagus; 2021 Oct; 18(4):743-752. PubMed ID: 33826001
[TBL] [Abstract][Full Text] [Related]
34. Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials.
Xiao S; Huang G; Zeng W; Zhou J; Li Y; Fan T; Liu X; Xia J; Zeng X
Clin Transl Oncol; 2023 Mar; 25(3):578-591. PubMed ID: 36315334
[TBL] [Abstract][Full Text] [Related]
35.
Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.
Liang Y; Liu JL; Wu Y; Zhang ZY; Wu R
Tohoku J Exp Med; 2011 Feb; 223(2):137-44. PubMed ID: 21304218
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical analysis on potential new molecular targets for esophageal cancer.
Maurer J; Schöpp M; Thurau K; Haier J; Köhler G; Hummel R
Dis Esophagus; 2014 Jan; 27(1):93-100. PubMed ID: 23551625
[TBL] [Abstract][Full Text] [Related]
38. ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer.
Sindhoo A; Sipy S; Khan A; Selvaraj G; Alshammari A; Casida ME; Wei DQ
Database (Oxford); 2023 Oct; 2023():. PubMed ID: 37815872
[TBL] [Abstract][Full Text] [Related]
39. The management of localized esophageal squamous cell carcinoma: Western approach.
Zaidi N; Kelly RJ
Chin Clin Oncol; 2017 Oct; 6(5):46. PubMed ID: 29129086
[TBL] [Abstract][Full Text] [Related]
40. A review of the current understanding and clinical utility of miRNAs in esophageal cancer.
Sakai NS; Samia-Aly E; Barbera M; Fitzgerald RC
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):512-21. PubMed ID: 24013023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
